ONCO
Onconetix, Inc. Common Stock
stock NASDAQ

ONCO news...

It had a spike to .90 late yesterday, really sat around .75 all day yesterday. So its kinda flat since yesterday.
That being said, it had a major dump (-30%) around the 10th (1.10 to .70-80's)
There's only like 700k shares total, so a strong fart tends to move it.
I am in $ONCO long term for the merger, with a ton of $XBOTF as well, so put high-as-possible limit sell orders on to suck up more. Fidelity been begging me for loaner shares. Fuck 'em.

ONCO get in early, 40X profits - 107% short interest - 0.5 Million market cap - 40 BILLION customer - AI Humanoid Robots

ONCO get in early, 40X profits - 107% short interest - 550K market cap - 40 BILLION customer - AI Humanoid Robots

# Top Small Cap Gainers (by % gain, under $1B market cap focus)
1. **ONCO (Onconetix, Inc.)** — **+13.75%** (to \~$0.91, high volume) **Why?** Ongoing momentum from AI/humanoid robotics pivot. Recent highlights include Realbotix's launch of the Vinci AI Vision System, delivery of the first Vinci-equipped humanoid robot to Ericsson, and new partnerships/innovations in oncology and men's health tech. (Note: Earlier reverse split helped maintain Nasdaq listing.)
2. **SOBR (SOBR Safe, Inc.)** — **+13.49%** (to \~$0.59) **Why?** Speculative buying in this micro-cap alcohol detection/safety tech name amid broader small-cap rotation and low-float volatility.
3. **NIVF (NewGenIvf Group Limited)** — **+8.96%** (to \~$2.19) **Why?** Positive sentiment around the company's transformation and entry into a growth phase (fertility/IVF services).
4. **LGHL (Lion Group Holding Ltd.)** — **+7.89%** (to \~$0.93) **Why?** Wholly-owned subsidiary granted exclusivity for restructuring Skyfame Realty (Holdings) Limited (in liquidation)—a potential catalyst for the financial services/holding company.
5. **FGL (Founder Group Limited)** — **+6.88%** (to \~$1.71) **Why?** Regained compliance with Nasdaq’s minimum publicly held shares requirement, removing a key delisting risk.

ONCO did came back from death...

ONCO trying to come back from death...

WHAT ARE THE BIGGEST LOSERS ?
* **Biotech/Clinical Catalysts** — REPL, LPCN, ONCO: Small biotechs are highly event-driven. A single disappointing trial result, FDA update, or missed endpoint can cause 20–60%+ drops in one day due to binary risk.
* **Low-Float Micro-Caps** — WORX, ONCO: These have tiny share floats and low trading volume. A few large sells can trigger cascading drops, stop-loss hunting, or panic selling.
|Rank|Ticker & Company|Approx. % Decline|Market Cap (Approx.)|Sector|Why It's Losing Today|
|:-|:-|:-|:-|:-|:-|
|1|**REPL**Replimune Group|\-64%|\~$140M|Biotech (Oncology)|Likely clinical trial disappointment, negative data readout, or safety concerns — common trigger for sharp biotech drops.|
|2|**WORX**SCWorx Corp.|\-31%|\~$1M|Healthcare Tech|Extremely low-float micro-cap; prone to heavy selling on thin volume or profit-taking after any prior run.|
|3|**PLCE**Children's Place|\-28%|\~$63M|Retail (Children's Apparel)|Weak earnings, poor guidance, or broader retail sector pressure (consumer spending concerns).|
|4|**AFJK** Aimei Health Technology|\-28%|\~$247M|Health Tech|Possible negative news, dilution, or sector rotation away from smaller health plays.|
|5|**ONCO**Onconetix|\-27%|Micro (\~$0.5M)|Biotech|High-volatility micro-cap; often reacts to trial updates, regulatory issues, or low-volume selloffs.|